India SMEs Forecast To Be Major Drivers Of Nation's Pharma Growth
This article was originally published in PharmAsia News
India's major drug makers are expected to be outpaced by small and medium pharmas as major contributors to the industry's near-term growth, already responsible for as much as 40% of it.
You may also be interested in...
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.